Eton Pharmaceuticals, Inc. (ETON)
62.66
-1.76
(-2.74%)
USD |
NASDAQ |
Aug 25, 14:59
Eton Pharmaceuticals Net Income (Quarterly) : 11.58M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.58M |
| March 31, 2026 | 1.554M |
| December 31, 2025 | 1.483M |
| September 30, 2025 | -1.927M |
| June 30, 2025 | -2.585M |
| March 31, 2025 | -1.572M |
| December 31, 2024 | -0.598M |
| September 30, 2024 | 0.627M |
| June 30, 2024 | -3.041M |
| March 31, 2024 | -0.811M |
| December 31, 2023 | -2.256M |
| September 30, 2023 | -0.579M |
| June 30, 2023 | 4.559M |
| March 31, 2023 | -2.66M |
| December 31, 2022 | 0.912M |
| September 30, 2022 | -3.045M |
| June 30, 2022 | -1.558M |
| March 31, 2022 | -5.33M |
| December 31, 2021 | 1.039M |
| Date | Value |
|---|---|
| September 30, 2021 | -6.094M |
| June 30, 2021 | -2.016M |
| March 31, 2021 | 5.116M |
| December 31, 2020 | -7.687M |
| September 30, 2020 | -6.504M |
| June 30, 2020 | -4.73M |
| March 31, 2020 | -9.049M |
| December 31, 2019 | -2.696M |
| September 30, 2019 | -4.965M |
| June 30, 2019 | -3.249M |
| March 31, 2019 | -7.41M |
| December 31, 2018 | -3.73M |
| September 30, 2018 | -2.91M |
| June 30, 2018 | -3.082M |
| March 31, 2018 | -3.018M |
| December 31, 2017 | -2.17M |
| September 30, 2017 | -2.802M |
| June 30, 2017 | -2.184M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Nektar Therapeutics | -40.62M |
| Pfizer Inc. | -246.00M |
| Elite Pharmaceuticals, Inc. | 5.911M |
| Daré Bioscience, Inc. | -2.983M |
| Liquidia Corp. | 74.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 37.59M |
| Total Expenses (Quarterly) | 26.01M |
| EPS Diluted (Quarterly) | 0.3531 |
| Enterprise Value | 1.825B |
| Gross Profit Margin (Quarterly) | 67.61% |
| Profit Margin (Quarterly) | 30.80% |
| Earnings Yield | 0.60% |
| Operating Earnings Yield | 0.86% |
| Normalized Earnings Yield | 0.6117 |